On May 20, HBV DNA Diagnostic Kit, HCV RNA Diagnostic Kit, and HIV-1 RNA Diagnostic Kit developed by Sansure Biotech Inc. have successfully obtained the European Union Notified Body Certificate (CE-IVD List A), making Sansure the first in China to receive the highest CE certificate for molecular testing reagents. HBV CE certificate (List A) HCV CE certificate (List A) HIV-1 […]

The World Health Organization (WHO) said on May 20 that recently, the organization received reports of about 80 cases of monkeypox from various countries, and another 50 cases are yet to be confirmed. WHO convened an expert and technical advisory group meeting on May 20 to discuss global information on monkeypox and its response. At present, several countries including the […]

On May 12, the Six Respiratory Pathogens Multiplex Nucleic Acid Diagnostic Kit (Multiplex PCR-Fluorescence Probing) developed by Sansure Biotech was approved for marketing (GXZZ 20223400597). It is the first domestic test reagent based on multiplex fluorescence PCR technology to detect six common bacteria in a single tube, and is also a revolutionary product for molecular diagnosis, adding to Sansure Biotech’ […]

Recently, the Novel Coronavirus (2019-nCoV) Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing) developed by Sansure Biotech has got UK CTDA approval, and before that, MHRA registration was completed for this product, meaning that the kits could be marketed in the UK legally. This is the first COVID-19 molecular testing reagent approved in China after the UK government implemented the new registration […]

The epidemic in Hong Kong has touched people’s hearts. With the sincere care for our compatriots in Hong Kong, on the morning of April 20, Sansure Biotech donated HK$6.3 million of Covid-19 antigen tests to the channel of Chinese Culture Foundation and Hunan Charity Federation for the prevention and control of the epidemic in Hong Kong schools, helping Hong Kong […]